Skip to main content
. 2019 Sep 15;34(3):257–266. doi: 10.1111/ppe.12582

Table 2.

The potential confounders

Feature Took drug Did not take drug OR (95% CI) P
Medical history
History of asthma 13.6% 9.9% 1.32 (1.15, 1.52) 1.0 × 10−4
History of indigestion 75.7% 66.2% 1.19 (1.08, 1.32) 0.001
History of back pain 52.6% 42.7% 1.11 (1.01, 1.22) 0.028
History of migraine 53.7% 36.5% 1.46 (1.33, 1.60) 5.4 × 10−16
Pre‐pregnancy BMIa M 23.3 M 22.6 1.03 (1.02, 1.04) 8.0 × 10−6
In period 18‐32 wk
In poor healthb 32.8% 18.8% 1.18 (1.12, 1.25) 8.0 × 10−9
Had a cold 48.5% 34.3% 1.44 (1.32, 1.59) 7.7 × 10−15
Had ‘flu 8.7% 3.8% 1.37 (1.10, 1.70) 0.005
Had other infection 7.1% 3.4% 1.33 (1.19, 1.49) 8.2 × 10−7
Had a headache 80.6% 46.4% 3.89 (3.52, 4.29) 5.5 × 10−160
Lifestyle
Healthy diet scorea M ‐ 0.11 M + 0.09 0.87 (0.83, 0.92) 2.4 × 10−8
Processed diet scorea M + 0.07 M ‐ 0.05 1.06 (1.01, 1.11) 0.014
Drank no alcohol 45.0% 53.7% 0.66 (0.60, 0.72) 1.1 × 10−19
Social conditions
Domestic chemical scorea M 11.4 M 10.5 1.02 (1.01, 1.03) 0.002
Parity 1+ 62.6% 49.4% 1.18 (1.12, 1.24) 6.2 × 10−11

Features of the mother that independently predicted whether she had taken paracetamol in the period 18‐32 weeks. Final model – N = 9522; pseudo‐R 2 = 14.35%. Details of variables are given in the Supplementary Material.

BMI, body mass index; CI, confidence interval; M, mean; OR, odds ratio or mean difference.

a

Odds ratio for a continuous scale.

b

Subjective measure reported by the mother at 32 wk.